Literature DB >> 6156979

Mode of regulation of natural killer cell activity by interferon.

N Minato, L Reid, H Cantor, P Lengyel, B R Bloom.   

Abstract

Whereas xenogeneic tumors such as baby hamster kidney or HeLa cells grow in nude mice, the same cells persistently infected with a variety of viruses are rejected. Spleen cells from normal nude mice were found to be induced to produce interferon and to exert natural killer (NK) activity on virus persistently infected (PI) tumor cells, and not on uninfected parental cells in vitro. The phenotype of the interferon-producing cells and the NK effector cells was found to be the same namely, Qa 5(+), Ly 5(+), ganglio-N- tetraosylceramide, with 35 percent of the NK cells also expressing Thy 1.2. NK activity against virus PI tumor cell lines could be nonspecifically augmented both in vivo and in vitro by prior contact with virus PI tumor cells. It was unambiguously demonstrated with chemically homogeneous mouse interferon that interferon, and not a contaminant, was responsible for the augmentation of NK activity in vitro. Studies on the mode of interferon action in augmenting NK activity revealed that the target cell for interferon action was serologically distinct from the NK effector cell. Anti-Ly 5 + complement (C)-treated spleen cells were depleted of NK activity and the ability to produce interferon, but, upon incubation with interferon for 1-3 h, regained both NK activity and susceptibility to anti-Ly 5 + C. Treatment with anti-Qa 5 + C eliminated NK activity, which could not be restored by the addition of interferon. We conclude that interferon produced by Ly 5(+) cells in response to virus PI tumor cells acts on Ly 5(-) precursor cells and induces their differentiation into functional Ly 5(+) NK effector cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6156979      PMCID: PMC2185902          DOI: 10.1084/jem.152.1.124

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  Virus carrier state suppresses tumorigenicity of tumor cells in athymic (nude) mice.

Authors:  L M Reid; C L Jones; J Holland
Journal:  J Gen Virol       Date:  1979-03       Impact factor: 3.891

2.  The beige mutation in the mouse selectively impairs natural killer cell function.

Authors:  J Roder; A Duwe
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

3.  Enhanced NK cell activity in mice injected with interferon and interferon inducers.

Authors:  M Gidlund; A Orn; H Wigzell; A Senik; I Gresser
Journal:  Nature       Date:  1978-06-29       Impact factor: 49.962

4.  Low density of Thy 1 antigen on mouse effector cells mediating natural cytotoxicity against tumor cells.

Authors:  R B Herberman; M E Nunn; H T Holden
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

5.  Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo.

Authors:  O Haller; M Hansson; R Kiessling; H Wigzell
Journal:  Nature       Date:  1977-12-15       Impact factor: 49.962

6.  "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype.

Authors:  R Kiessling; E Klein; H Wigzell
Journal:  Eur J Immunol       Date:  1975-02       Impact factor: 5.532

7.  Qat-4 and Qat-5, new murine T-cell antigens governed by the Tla region and identified by monoclonal antibodies.

Authors:  G J Hämmerling; U Hämmerling; L Flaherty
Journal:  J Exp Med       Date:  1979-07-01       Impact factor: 14.307

8.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.

Authors:  G Trinchieri; D Santoli
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

9.  Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice.

Authors:  N Minato; B R Bloom; C Jones; J Holland; L M Reid
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307

10.  Direct evidence that natural killer cells in nonimmune spleen cell populations prevent tumor growth in vivo.

Authors:  M Kasai; J C Leclerc; L McVay-Boudreau; F W Shen; H Cantor
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307

View more
  38 in total

1.  Treatment of early stage-B chronic lymphocytic leukemia with alpha-2b interferon after chlorambucil reduction of the tumoral mass.

Authors:  E Montserrat; N Villamor; A Urbano-Ispizua; J M Ribera; M Lozano; J L Vives-Corrons; C Rozman
Journal:  Ann Hematol       Date:  1991-07       Impact factor: 3.673

Review 2.  Natural killer activity: early days, advances, and seminal observations.

Authors:  John R Ortaldo; Robert H Wiltrout; Craig W Reynolds
Journal:  Crit Rev Oncog       Date:  2014

3.  Age distribution of circulating alpha-interferon.

Authors:  S Shiozawa; K Shiozawa; S Shimizu; Y Tanaka; I Morimoto; Y Kuroki; R Yoshihara; T Fujita
Journal:  Experientia       Date:  1989-08-15

4.  Predictors of survival in human immunodeficiency virus type 1-seropositive intravenous drug users.

Authors:  J B Page; S Lai; M A Fletcher; R Patarca; P C Smith; H C Lai; N G Klimas
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

5.  In vitro production of different interferon types by cloned human NK cells.

Authors:  A Nocera; G Melioli; A Merli; F Santoro; A Zicca
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

6.  Mutations in mice that influence natural killer (NK) cell activity.

Authors:  E A Clark; L D Shultz; S B Pollack
Journal:  Immunogenetics       Date:  1981-03-01       Impact factor: 2.846

7.  Natural interferon-producing cells in mice.

Authors:  Y Ito; H Aoki; Y Kimura; M Takano; K Shimokata; K Maeno
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

8.  Influence of anti-mouse interferon serum on the growth and metastasis of tumor cells persistently infected with virus and of human prostatic tumors in athymic nude mice.

Authors:  L M Reid; N Minato; I Gresser; J Holland; A Kadish; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

9.  The development of NK cell activity in thymectomized bone marrow chimaeras.

Authors:  M Sihvola; M Hurme
Journal:  Immunology       Date:  1984-09       Impact factor: 7.397

10.  IFN-treatment of B16-F1 versus B16-F10: relative impact on non-adaptive and T-cell-mediated immune defense in metastatic spread.

Authors:  M Zöller
Journal:  Clin Exp Metastasis       Date:  1988 Sep-Oct       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.